Processa Pharmaceuticals, Inc. Increase (Decrease) in Interest Payable, Net
Processa Pharmaceuticals, Inc. (PCSA) reported Increase (Decrease) in Interest Payable, Net of $362 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-30.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInterestPayableNet · last filed 2022-11-08
- Processa Pharmaceuticals, Inc. increase (decrease) in interest payable, net for the quarter ending 2021-12-31 was $0.00, a 100.00% decline year-over-year.
- Processa Pharmaceuticals, Inc. increase (decrease) in interest payable, net for the quarter ending 2021-09-30 was $0.00, a 100.00% decline year-over-year.
- Processa Pharmaceuticals, Inc. increase (decrease) in interest payable, net for the quarter ending 2021-06-30 was $0.00, a 100.00% decline year-over-year.
- Processa Pharmaceuticals, Inc. increase (decrease) in interest payable, net for the quarter ending 2021-03-31 was $362.00, a 97.75% decline year-over-year.
- Processa Pharmaceuticals, Inc. increase (decrease) in interest payable, net for fiscal 2021 was $362.00, a 99.56% decline from fiscal 2020.
- Processa Pharmaceuticals, Inc. increase (decrease) in interest payable, net for fiscal 2020 was $81.89K, a 168.60% increase from fiscal 2019.
- Processa Pharmaceuticals, Inc. increase (decrease) in interest payable, net for fiscal 2019 was $30.49K, a 67.61% decline from fiscal 2018.
- Processa Pharmaceuticals, Inc. increase (decrease) in interest payable, net for fiscal 2018 was $94.12K, a 163.70% increase from fiscal 2017.
| Period end | Increase (Decrease) in Interest Payable, Net 3 month | Increase (Decrease) in Interest Payable, Net 3 month as first filed | Increase (Decrease) in Interest Payable, Net 6 month | Increase (Decrease) in Interest Payable, Net 6 month as first filed | Increase (Decrease) in Interest Payable, Net 9 month | Increase (Decrease) in Interest Payable, Net 9 month as first filed | Increase (Decrease) in Interest Payable, Net 12 month | Increase (Decrease) in Interest Payable, Net 12 month as first filed | Increase (Decrease) in Interest Payable, Net 27 month | Increase (Decrease) in Interest Payable, Net 30 month | Increase (Decrease) in Interest Payable, Net 33 month |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $0.00 derived: sum of 2 quarters · filed 2022-11-08 | $0.00 derived: sum of 3 quarters · filed 2022-11-08 | $362.00 10-K · filed 2022-03-30 | |||||||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $0.00 derived: sum of 2 quarters · filed 2022-11-08 | $362.00 10-Q · filed 2022-11-08 | $14.45K derived: sum of 4 quarters · filed 2022-11-08 | |||||||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $362.00 10-Q · filed 2022-08-11 | $14.45K derived: sum of 3 quarters · filed 2022-08-11 | $45.67K derived: sum of 4 quarters · filed 2022-08-11 | |||||||
| 2021-03-31 | $362.00 10-Q · filed 2022-05-12 | $14.45K derived: sum of 2 quarters · filed 2022-05-12 | $45.67K derived: sum of 3 quarters · filed 2022-05-12 | $66.16K derived: sum of 4 quarters · filed 2022-05-12 | |||||||
| 2020-12-31 | $14.09K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $45.31K derived: sum of 2 quarters · filed 2022-03-30 | $65.79K derived: sum of 3 quarters · filed 2022-03-30 | $81.89K 10-K · filed 2022-03-30 | |||||||
| 2020-09-30 | $31.22K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $51.70K derived: sum of 2 quarters · filed 2021-11-12 | $67.80K 10-Q · filed 2021-11-12 | $89.70K derived: sum of 4 quarters · filed 2021-11-12 | |||||||
| 2020-06-30 | $20.48K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $36.58K 10-Q · filed 2021-08-12 | $58.48K derived: sum of 3 quarters · filed 2021-08-12 | $58.48K derived: sum of 4 quarters · filed 2021-08-12 | |||||||
| 2020-03-31 | $16.10K 10-Q · filed 2021-05-13 | $38.00K derived: sum of 2 quarters · filed 2021-05-13 | $38.00K derived: sum of 3 quarters · filed 2021-05-13 | $41.99K derived: sum of 4 quarters · filed 2021-05-13 | |||||||
| 2019-12-31 | $21.90K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $21.90K derived: sum of 2 quarters · filed 2021-03-25 | $25.89K derived: sum of 3 quarters · filed 2021-03-25 | $30.49K 10-K · filed 2021-03-25 | |||||||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $3.99K derived: sum of 2 quarters · filed 2020-11-12 | $8.59K 10-Q · filed 2020-11-12 | $13.19K derived: sum of 4 quarters · filed 2020-11-12 | |||||||
| 2019-06-30 | $3.99K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $8.59K 10-Q · filed 2020-08-05 | $13.19K derived: sum of 3 quarters · filed 2020-08-05 | $17.99K derived: sum of 4 quarters · filed 2020-08-05 | |||||||
| 2019-03-31 | $4.60K 10-Q · filed 2020-05-15 | $9.20K derived: sum of 2 quarters · filed 2020-05-15 | $14.00K derived: sum of 3 quarters · filed 2020-05-15 | $47.12K derived: sum of 4 quarters · filed 2020-05-15 | |||||||
| 2018-12-31 | $4.60K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-06 | $9.40K derived: sum of 2 quarters · filed 2020-03-06 | $42.52K derived: sum of 3 quarters · filed 2020-03-06 | $94.12K 10-K · filed 2020-03-06 | |||||||
| 2018-09-30 | $4.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $37.92K derived: sum of 2 quarters · filed 2019-11-14 | $89.52K 10-Q · filed 2019-11-14 | -$46.73K derived: sum of 4 quarters · filed 2019-11-14 | |||||||
| 2018-06-30 | $33.12K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $84.72K 10-Q · filed 2019-08-14 | $84.92K 10-Q · filed 2018-08-14 | -$51.53K derived: sum of 3 quarters · filed 2019-08-14 | -$4.94K derived: sum of 4 quarters · filed 2019-08-14 | ||||||
| 2018-03-31 | $51.60K 10-Q · filed 2019-05-14 | -$84.65K derived: sum of 2 quarters · filed 2019-05-14 | -$38.06K derived: sum of 3 quarters · filed 2019-05-14 | $25.35K derived: sum of 4 quarters · filed 2019-05-14 | |||||||
| 2017-12-31 | -$136.25K derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-04-08 | -$89.66K derived: sum of 2 quarters · filed 2019-04-08 | -$26.25K derived: sum of 3 quarters · filed 2019-04-08 | $35.69K 10-K/A · filed 2019-04-08 | |||||||
| 2017-09-30 | $46.58K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-20 | $109.99K derived: sum of 2 quarters · filed 2017-11-20 | $171.94K 10-Q · filed 2017-11-20 | $235.26K derived: sum of 4 quarters · filed 2017-11-20 | |||||||
| 2017-06-30 | $63.41K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-10-04 | $125.36K 10-Q · filed 2017-10-04 | $188.68K derived: sum of 3 quarters · filed 2017-10-04 | $252.00K derived: sum of 4 quarters · filed 2017-11-20 | |||||||
| 2017-03-31 | $61.95K 10-Q · filed 2017-10-04 | $125.27K derived: sum of 2 quarters · filed 2017-10-04 | $188.59K derived: sum of 3 quarters · filed 2017-11-20 | $251.22K derived: sum of 4 quarters · filed 2017-11-20 | |||||||
| 2016-12-31 | $63.32K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-25 | $126.64K derived: sum of 2 quarters · filed 2017-11-20 | $189.28K derived: sum of 3 quarters · filed 2017-11-20 | $240.18K 10-K · filed 2017-09-25 | |||||||
| 2016-09-30 | $63.32K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-20 | $125.95K derived: sum of 2 quarters · filed 2017-11-20 | $176.85K 10-Q · filed 2017-11-20 | $245.28K derived: sum of 4 quarters · filed 2017-11-20 | |||||||
| 2016-06-30 | $62.63K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-10-04 | $113.53K 10-Q · filed 2017-10-04 | $181.96K derived: sum of 3 quarters · filed 2017-10-04 | $240.01K derived: sum of 4 quarters · filed 2017-10-04 | |||||||
| 2016-03-31 | $50.90K 10-Q · filed 2017-10-04 | $119.33K derived: sum of 2 quarters · filed 2017-10-04 | $177.38K derived: sum of 3 quarters · filed 2017-10-04 | $202.81K derived: sum of 4 quarters · filed 2017-10-04 | |||||||
| 2015-12-31 | $68.43K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-25 | $126.48K derived: sum of 2 quarters · filed 2017-09-25 | $151.91K derived: sum of 3 quarters · filed 2017-09-25 | $153.79K 10-K · filed 2017-09-25 | |||||||
| 2015-09-30 | $58.05K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-09-08 | $83.49K derived: sum of 2 quarters · filed 2017-09-08 | $85.36K 10-Q · filed 2017-09-08 | $98.97K 10-Q · filed 2015-12-01 | $85.07K derived: sum of 4 quarters · filed 2017-09-08 | ||||||
| 2015-06-30 | $25.44K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-30 | $27.31K 10-Q · filed 2017-08-30 | $45.98K 10-Q · filed 2015-08-19 | $27.02K derived: sum of 3 quarters · filed 2017-08-30 | $34.93K derived: sum of 4 quarters · filed 2017-08-30 | ||||||
| 2015-03-31 | $1.87K 10-Q · filed 2017-08-07 | $8.88K 10-Q · filed 2015-05-15 | $1.58K derived: sum of 2 quarters · filed 2017-08-07 | $9.49K derived: sum of 3 quarters · filed 2017-08-07 | $9.07K derived: sum of 4 quarters · filed 2017-08-07 | ||||||
| 2014-12-31 | -$291.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-06-19 | $7.62K derived: sum of 2 quarters · filed 2017-06-19 | $7.20K derived: sum of 3 quarters · filed 2017-06-19 | $6.01K 10-K · filed 2017-06-19 | $50.26K 10-K · filed 2015-04-14 | ||||||
| 2014-09-30 | $7.91K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-12-01 | $7.49K derived: sum of 2 quarters · filed 2015-12-01 | $6.30K 10-Q · filed 2015-12-01 | $5.48K derived: sum of 4 quarters · filed 2015-12-01 | |||||||
| 2014-06-30 | -$422.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-19 | -$1.61K 10-Q · filed 2015-08-19 | -$2.43K derived: sum of 3 quarters · filed 2015-08-19 | -$2.43K derived: sum of 4 quarters · filed 2015-08-19 | |||||||
| 2014-03-31 | -$1.19K 10-Q · filed 2015-05-15 | -$2.00K derived: sum of 2 quarters · filed 2015-05-15 | -$2.00K derived: sum of 3 quarters · filed 2015-05-15 | ||||||||
| 2013-12-31 | -$818.00 derived: 10-K 33 month − 10-Q 30 month · filed 2014-03-27 | -$818.00 derived: sum of 2 quarters · filed 2014-03-27 | -$818.00 10-K · filed 2015-04-14 | $1.81K 10-K · filed 2014-03-27 | |||||||
| 2013-09-30 | $0.00 derived: 10-Q 30 month − 10-Q/A 27 month · filed 2013-11-08 | $2.63K 10-Q · filed 2013-11-08 | |||||||||
| 2013-06-30 | $2.63K 10-Q/A · filed 2013-09-06 | ||||||||||
| 2012-12-31 | $164.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | -$7.23K derived: sum of 2 quarters · filed 2014-03-27 | -$7.89K 10-K · filed 2014-03-27 | ||||||||
| 2012-09-30 | -$7.40K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-11-08 | -$8.05K 10-Q · filed 2013-11-08 | |||||||||
| 2012-06-30 | -$658.00 10-Q/A · filed 2013-09-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |